Exploring a New Clinical Trial for KIT-Mutant GIST
Dr. Candace Haddox will discuss a new clinical trial combining ripretinib and navlimetostat for patients with KIT-mutant GIST and MTAP gene deletion, including eligibility and enrollment details.
1 event found.